Review of foreign scientists from countries like China began even before three Chinese scientists in Michigan were caught ...

In 2021, the Wall Street Journal reported that Memoli -- who had opposed mandatory COVID vaccinations and declined to be vaccinated -- was primed to make the case against such mandates at an NIH ...

Flaws cited by a trial brief brought by the groups included the lack of a definition for what qualified as banned "DEI studies" and NIH Acting Director Dr. Matthew Memoli having spent only minutes ...

President Donald Trump might not care for the World Health Organization’s advice, but that isn’t stopping one of its top officials from warning his administration about what’s at stake as measles ...

Principal Deputy Director of the NIH Matthew Memoli, M.D., announced the RFI at the Coalition for Health AI’s semi-annual meeting at Stanford Medicine on Thursday.

The Trump administration has launched a $500 million project to develop a universal flu vaccine that won't need yearly updates. But vaccine experts are mystified by its focus on a dated technology.

Nearly two weeks after the court’s preliminary injunction was issued, the National Institutes of Health’s then-acting head, Dr. Matthew J. Memoli, drafted a memo that details how the agency ...

As interim director, Memoli oversaw the start of the administration’s massive cuts at the NIH, with the elimination of some 800 agency grants worth over $2 billion.

Matthew J. Memoli has had an exceptionally good year. At the beginning of January, Memoli was a relatively little-known flu researcher running a small lab at the National Institute for Allergy and ...

As interim director, Memoli oversaw the start of the administration’s massive cuts at the NIH, with the elimination of some 800 agency grants worth more than $2 billion.

The vaccine is being developed at the National Institute for Allergy and Infectious Diseases by Jeffery Taubenberger, whom Trump named as acting chief of the institute in late April, and his colleague ...